손바닥선인장 추출물을 함유하는 약학 조성물
    2.
    发明授权
    손바닥선인장 추출물을 함유하는 약학 조성물 有权
    药物组合物,其包含来自仙人掌榕的提取物

    公开(公告)号:KR101164020B1

    公开(公告)日:2012-07-18

    申请号:KR1020060095383

    申请日:2006-09-29

    Abstract: 본 발명은 손바닥선인장 추출물을 함유하는 약학 조성물에 관한 것으로, 더욱 상세하게는 손바닥선인장의 부탄올 추출물 또는 이 추출물의 산 가수분해물이 유효성분으로 함유되어 있음으로써 뇌신경 질환, 뇌혈관 질환 또는 심혈관 질환 보다 구체적으로는 뇌졸중, 뇌진탕, 알쯔하이머병, 파킨슨병, 뇌경색, 심근경색 등의 치료 및 예방에 유효한 약학 조성물에 관한 것이다.
    손바닥선인장, 부탄올 추출물, 뇌졸중, 허혈, 신경세포 보호, 뇌신경질환

    물오리나무 줄기 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
    3.
    发明公开
    물오리나무 줄기 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물 有权
    含有来自ALNUS HIRSUTA和其分离的化合物的提取物的肝细胞保护性组合物

    公开(公告)号:KR1020100084038A

    公开(公告)日:2010-07-23

    申请号:KR1020090003430

    申请日:2009-01-15

    CPC classification number: A61K31/7032 A61K36/185 Y10S514/893

    Abstract: PURPOSE: A composition containing Alnus hirsute stem extract or a compound isolated from the same is provided to protect hepatocytes and to prevent and treat liver diseases. CONSTITUTION: A composition for preventing and treating hepatotoxicity contains Alnus hirsute stem extract as an active ingredient. A composition for preventing and treating hepatotoxicity contains a compound of chemical formula 1 as an active ingredient. A method for preparing the Alnus hirsute extract comprises: a step of adding 0.1-10L of alcohol per 1kg of cut Alnus hirsute stem and refluxing at 60-100 °C for 2 to 6 hours; a step of filtering and decompressing extract; and a step of extracting with 1-5L of ethylacetate to obtain fraction.

    Abstract translation: 目的:提供含有Alnus多毛茎提取物或从其分离的化合物的组合物以保护肝细胞并预防和治疗肝脏疾病。 构成:用于预防和治疗肝毒性的组合物含有阿尔金斯多毛提取物作为活性成分。 用于预防和治疗肝毒性的组合物含有化学式1的化合物作为活性成分。 一种制备Al ute提取物的方法,其特征在于,每1kg切割的Al藜茎加入0.1-10L的酒精并在60-100℃下回流2至6小时; 过滤和解压缩提取步骤; 和用1-5L乙酸乙酯萃取以获得级分的步骤。

    층꽃풀로부터 분리된 페놀계 화합물을 함유하는 간보호용 조성물
    6.
    发明公开
    층꽃풀로부터 분리된 페놀계 화합물을 함유하는 간보호용 조성물 有权
    包含从CARYOPTERIS INCANA分离的酚化合物的保护性药物组合物

    公开(公告)号:KR1020130086580A

    公开(公告)日:2013-08-02

    申请号:KR1020130069884

    申请日:2013-06-18

    Abstract: PURPOSE: A Caryopteris incana extract, a fraction thereof, and a compound isolated from the extract or the fraction, and a composition containing the same for protecting liver are provided to protect liver cells from hepatotoxicity caused by toxic materials and to prevent and treat liver diseases. CONSTITUTION: A pharmaceutical composition for a liver protective agent contains one or more kinds of compounds selected among compounds of chemical formulas 1-3, 5, and 8-10. The compounds protect liver cells from toxicity induced by tertiary-butyl hydroperoxide (t-BHP). A food composition for protecting liver contains one or more kinds of compounds selected among the compounds of chemical formulas 1-3, 5, and 8-10. The compound of chemical formula 1 or 2 is isolated from Caryopteris incana.

    Abstract translation: 目的:提供Caryopteris incana提取物及其一部分,从提取物或级分分离的化合物和含有该化合物的组合物用于保护肝脏,以保护肝细胞免受有毒物质引起的肝毒性并预防和治疗肝脏疾病 。 构成:用于肝保护剂的药物组合物含有选自化学式1-3,5和8-10的化合物中的一种或多种化合物。 该化合物可保护肝细胞免受叔丁基过氧化氢(t-BHP)诱导的毒性。 用于保护肝的食品组合物含有选自化学式1-3,5和8-10的化合物中的一种或多种化合物。 化学式1或2的化合物从ary is分离。

    손바닥선인장 열매의 종자 추출물 또는 이로부터 분리된화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
    9.
    发明公开
    손바닥선인장 열매의 종자 추출물 또는 이로부터 분리된화합물을 함유하는 간독성 질환 예방 및 치료용 조성물 有权
    包含来自OPENTIA FICUS-INDICA VAR的种子的提取物的肝毒性疾病组合物。 SABOTEN和化合物分离

    公开(公告)号:KR1020090086817A

    公开(公告)日:2009-08-14

    申请号:KR1020080012293

    申请日:2008-02-11

    Abstract: A composition for preventing and treating hepatotoxic diseases, which contains Opuntia ficus-indica var. saboten seed extract or compound isolated from the extract is provided to have excellent liver protection effect and liver recovery effect in generation of hepatotoxicity. A composition for preventing and treating hepatotoxicity comprises an alcohol extract of Opuntia ficus-indica var. saboten seed as an active ingredient. A method for producing the alcohol extract of Opuntia ficus-indica var. saboten seed comprises: a step of adding 0.1-10 ‘± of alcohol solvent per 1kg of seed powder and performing reflux at 60-100‹C for two to six hours; and a step of filtering and compressing. The method further comprises a step of adding 1-5L of ethylacetate(EtOAc) to have fraction.

    Abstract translation: 一种用于预防和治疗肝毒性疾病的组合物,其含有榕属梧桐菜(Opuntia ficus-indica var。 提供从提取物中分离得到的沙棘籽提取物或化合物,具有优异的肝脏保护作用和肝脏回收效果。 用于预防和治疗肝毒性的组合物包括榕属梧桐变种的醇提取物。 saboten种子作为活性成分。 一种生产榕果芸香醇提取物的方法 破碎种子包括:每1kg种子粉末加入0.1-10'醇醇溶剂并在60-100℃下回流2至6小时的步骤; 以及过滤和压缩的步骤。 该方法还包括加入1-5L乙酸乙酯(EtOAc)以具有级分的步骤。

    층꽃풀 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
    10.
    发明公开
    층꽃풀 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물 有权
    包含来自阴囊炎的提取物的化学保护性药物组合物及其分离的化合物

    公开(公告)号:KR1020120119105A

    公开(公告)日:2012-10-30

    申请号:KR1020110036866

    申请日:2011-04-20

    CPC classification number: A61K36/53

    Abstract: PURPOSE: A composition for preventing and treating hepatotoxicity diseases containing caryopteris incana extracts or a compound separated from the same is provided to enhance protective effectson hepatic cells. CONSTITUTION: A composition for preventing and treating hepatotoxicity diseases contains caryopteris incana extracts or a compound separated from the same. The caryopteris incana extract is obtained by extracting the caryopteris incana with water, C1-C4 alcohol or a mixed solvent thereof. The alcohol is methanol or ethanol. The caryopteris incana fraction is a fractions obtained by dichloromethane(CH2Cl2), ethyl acetate or butanol. The caryopteris incana extracts are compounds represented by chemical formula 1-10. The hepatotoxicity disease is drug caused liver damage, viral liver damage, hepatitis, liver hardening, liver cancer or hepatic coma. A pharmaceutical composition for preventing and treating the hepatotoxicity diseases includes the compound of the chemical formula 1-10 or salt which is pharmaceutically acceptable.

    Abstract translation: 目的:提供一种用于预防和治疗含有鳞翅目植物提取物或与其分离的化合物的肝毒性疾病的组合物,以增强对肝细胞的保护作用。 构成:用于预防和治疗肝毒性疾病的组合物含有鳞翅目刺槐提取物或从其分离的化合物。 通过用水,C 1 -C 4醇或其混合溶剂萃取ary is is,获得ary ana提取物。 醇是甲醇或乙醇。 鳞翅目分数是通过二氯甲烷(CH 2 Cl 2),乙酸乙酯或丁醇得到的级分。 ary ana提取物是化学式1-10表示的化合物。 肝毒性疾病是药物引起肝损害,病毒性肝损伤,肝炎,肝硬化,肝癌或肝昏迷。 用于预防和治疗肝毒性疾病的药物组合物包括化学式1-10的化合物或药学上可接受的盐。

Patent Agency Ranking